Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Krsnaa Diagnostics has informed that the Board of Directors of the Company vide resolution passed by circulation on November 27, 2023, has allotted in aggregate 8,92,150 equity shares of face value of Rs 5 each, to eligible employees pursuant to exercise of options under ESOS 2020 of the Company. Consequent to the aforesaid allotment, the issued, subscribed and paid-up equity share capital of the Company stands increased from 3,13,97,613 equity shares of Rs 5 each aggregating to Rs 15,69,88,065 to 3,22,89,763 equity shares of Rs 5 each aggregating to Rs 16,14,48,815. The details as required to be furnished under the Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 is enclosed as Annexure -I.
